ARCHIVES

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

Low-Dose Aspirin Cuts Risk Of Colorectal Growths

April 26, 2002

Maggie’s Bill Pays Off; NCI Celebrates 40th

August 12, 1977

NALSO Members Urged To Police Selves, Adopt Ethics Code

August 4, 1978

Brown’s appointment may Be Delayed Until After Jan. 20

January 14, 1977

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990